← Open Payments lookup

NATALIE VANDERBLEEK: Open Payments

NPI 1861033508 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$956 in 41 payments from 15 companies in 2025. Trend: 2023 $78 · 2024 $197 · 2025 $956

Food & beverage: $956
CompanyPaymentsAmount
PFIZER INC.10$185
Amgen Inc.8$134
Novo Nordisk Inc1$117
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)1$108
Novartis Pharmaceuticals Corporation4$71
Bayer Healthcare Pharmaceuticals Inc.3$57
Alnylam Pharmaceuticals Inc.3$55
AstraZeneca Pharmaceuticals LP3$49
Boehringer Ingelheim Pharmaceuticals, Inc.2$40
Takeda Pharmaceuticals U.S.A., Inc.1$35

Products named: VYNDAQEL, REPATHA, Ozempic, LifeVest, Kerendia, LEQVIO, AMVUTTRA, FARXIGA.

Industry payments across AL — which companies pay providers there.